stalled weight loss on semaglutide medications have been clinically effective for years. The problem was never efficacy. It was continuation. In real-world settings, the most common reasons patients stop GLP-1 therapy aren't about results they're Semaglutide results week by week:

Never adjust or discontinue either medication without medical guidance

What to Expect with Semaglutide Treatment Beginning with the smallest effective dose, your provider will gradually increase it based on your individual needs and how your body responds

dpp-4_inhibitors DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)

los agonistas GLP-1 disponibles son inyectables u orales y se usan como terapia crnica mientras demuestren beneficio clnico y buena tolerabilidad

The relevant clinical conversation, when it becomes one, is for patients who plateau on existing therapy or who would otherwise be candidates for bariatric surgery a population for whom retatrutide's responder rates start to look like a genuine alternative